agilon health priced pricing its underwritten public offering of 17 million shares by certain selling stockholders at an offering price of $30 per share. The underwriters have a 30-day option to purchase up to an additional 2.55 million shares. agilon health will not receive any proceeds from the secondary offering., which is expected to close Sept. 14. Read more.
Related Posts
Shore Capital Partners Welcomes Hires Brad Morehead as Partner, Head of Business Services Fund
Morehead will lead partnerships and transactions, including investment sourcing and valuation, transaction structuring and corporate development.
September 17, 2021
Gilmartin Capital Launches Inaugural Fund
Gilmartin Capital will focus on investment opportunities within the medical device, life science tools, diagnostics, and digital health sectors.
November 17, 2021
American Cancer Society’s Impact Investment Fund Secures First Three Contributions Totaling $2.5M
BrightEdge is the American Cancer Society's donor-funded impact venture capital fund.
November 16, 2021
Shore Capital Partners Raises $360M Health Care Fund: Report
Shore now has more than $2 billion of capital under management.
August 26, 2021